100 Years after the Spanish Flu Pandemic. The Evolution of the Influenza Virus and the Development of the Flu Vaccine
Abstract
The report includes a historical panorama of flu epidemics and pandemic from Hippocrates to the present day. An in-depth analysis of the pandemics and epidemics of the 20th and 21st centuries is given. The characteristics of the influenza virus, its epidemiology and the system of infection surveillance are presented. In the historical, scientific and practical aspects, relevancy for specific prevention of influenza has been considered.
About the Author
N. I. Briko
Sechenov University
Russian Federation
Russian Federation
Nikolay I. Briko – academic of the Russian Academyof Sciences, Dr. Sci. (Med.), professor, head of the department of epidemiology and evidencebased medicine at Sechenov University
Moscow
References
1. Chronicle of Influenza Pandemics, CW Potter. In: Textbook of Influenza. Eds.: Nicholson, Webster & Hay. Blackwell Science, Oxford, 1998: 3–19.
2. History of influenza pandemics. In: Paleomicrobiology: Past Human Infections. Ed.: D. Raoult and M. Drancourt. Springer-Verlag Berlin Heidelberg. 2008.
3. Morens D. M., Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 2008; 198: XXX–XX.
4. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004; 23: S87–S97.
5. Engelich G, White M, Hartshorn KL. Neutrophil survival is markedly reduced by incubation with influenza virus and Streptococcus pneumoniae: role of respiratory burst. J Leukoc Biol, 2001; 69: 50–56.
6. Sun K, Metzger DW. Inhibition of pulmonary antibacterial defense by interferon-γ during recovery from influenza infection. Nature Med. 2008;14:558–564
7. http://www.who.int/csr/disease/OP_GISRS_FINAL.pdf
8. Hui Li, Bin Cao. Pandemic and avian influenza A viruses in humans. Epidemiology, Virology, Clinical Characteristics, and Treatment strategy.//Clin. Chest. Med. 2017; 38: 59–70. Available at: http://www.who.int/influenza/gisrslaboratory/updates/summaryreport Accessed February 21, 2016.
9. Garten RJ Davis CT, Russell CA, Shu B, Lindstrom S, Balish A. et al. Antigenic and Genetic Characteristics of the Early Isolates of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in Humans. Science, 22 May 2009; doi: 10.1126/science.1176225.
10. Summary report of a High-Level Consultation: new influenza A (H1N1) Geneva, 18 May 2009.// INFORMATION NOTE/2009/2, 20 May 2009
11. Карпова Л. С., Пелих М. Ю., Столяров К. А., Поповцева Н. М., Столярова Т. П. Пандемия гриппа в России как часть глобального распространения гриппа A(H1N1)pdm09 в 2009–2011 гг. Вопросы вирусологии 2012; 3: 26–30
12. Письмо Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека от 13 апреля 2010 г. N 01/5578-10-32: Об итогах пандемии гриппа А/H1N1/09 в мире и Российской Федерации в эпидсезон 2009–2010 гг. и прогнозе на эпидсезон 2010–2011 гг.
13. MMWR May 22, 2009; 58 (190). Доступно на сайте: www.cdc.gov/mmvr
14. Ray R., Dos Santos G., Buck P. O., Claeys C., Matias G., Innis B. L. et al. A review of the value of quadrivalent influenza vaccines and their potential contribution to influenza control.// Human vaccines and immunotherapeutics 2017; 13; 7: 1640–1652.
15. Ambrose Ch. S., Levin M. J. Rationale for quadrivalent infuenza vaccines.//Human Vaccines & Immunotherapeutics 2014; 8: 1, 81–88, DOI: 10.4161/hv.8.1.17623
16. Diaz Granados, C.A., Denis M., Plotkin S. Vaccine, 2012. 31 (1): 49–57.
17. Tricco, A.C. Chit A., Soobiah C., et al.: Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and metaanalysis. BMC Med, 2013; 11: 153.
18. Chagvardieff A. Persico N., Marmillot C., Badiaga S., Charrel R., Roch A. et.al Prospective comparative study of characterisctics associated with influenza A and B in adults. Medecine et maladies, 2017.
19. Bennet R., Hamrin J., Zweygberg Wirgart B., Rotzen Ostlund M., Ortqvist. Influenza epidemiology among hospitalized children in Stockholm, Sweden. Vaccine 2016; 34: 3298–3302.
20. Харит С. М., Рудакова А. В., Усков А. Н., Коновалова Л. Н., Лобзин Ю. В. Предотвращенный ущерб при вакцинации против гриппа 3и 4-валентными вакцинами. Журнал инфектологии. 2017; 2: 17–22.
21. Интегрированные данные заболеваемости и диагностики гриппа и ОРВИ, ФГБУ НИИ гриппа. Доступно на: http://www.influenza.spb.ru/import/2018_23_ld_ru/file048.pdf
22. Iuliano A D. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. Published online December 13, 2017.
23. Nair H Nair H, Brooks WA, Katz M, Roca A, Berkley JA, Madhi SA et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. The Lancet, 2011, 378:1917–1930.
Review
For citations:
Briko N.I. 100 Years after the Spanish Flu Pandemic. The Evolution of the Influenza Virus and the Development of the Flu Vaccine. Epidemiology and Vaccinal Prevention. 2018;17(4):68-75. (In Russ.)
Views:
1400
Email this article 